Table of Contents
Representatives from biotech and pharma companies will provide updates on their drug development efforts in the DM field:
About the presenters:
Kristina Bowyer
Ionis Pharmaceuticals
Vice President, Patient Advocacy
Art Levin, PhD
Avidity Biosciences
Chief Scientific Officer
Dietrich A. Stephan, PhD
NeuBase Therapeutics
Chief Executive Officer
Romesh Subramanian, PhD
Dyne Therapeutics
Chief Scientific Officer
